News Quantified

CTMX – cytomx therapeutics, inc. (US:NASDAQ)

CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) [Seeking Alpha]

12/21

07:42 am

ctmx

Low

Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress [Yahoo! Finance]

CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling [Seeking Alpha]

What Analysts Think Is Changing the CytomX Therapeutics Story After Recent Cancer Developments [Yahoo! Finance]

CytomX Therapeutics to Present at Upcoming December Investor Conferences [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}